Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gordon James who wrote (201)	8/30/1999 8:07:00 PM
From: Vector1	Read Replies (4) of 427

Gordon, three of the four analysts Tang Leheny and Toth maintained their buy ratings. Ende at Lehman who was a soft buy bolted. Ginzberg at Piper must be on vacation. That said I it is not clear yet where the stock will rally. I believe the company will refile by the end of September which will result in a 3 month delay. The question is how can something like this happen. CLTR regulatory people should have regular contact with the FDA. Is it possible that this is the staffs way of giving themselves a 9 month review? THis has been a bad day. V1

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next